Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells

M. Svedova, J. Masin, R. Fiser, O. Cerny, J. Tomala, M. Freudenberg, L. Tuckova, M. Kovar, G. Dadaglio, I. Adkins, P. Sebo,

. 2016 ; 94 (4) : 322-33. [pub] 20151006

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000975
E-zdroje Online Plný text

NLK ProQuest Central od 2000-02-01 do 2019-01-31
Health & Medicine (ProQuest) od 2000-02-01 do 2019-01-31

Odkazy

PubMed 26437769
DOI 10.1038/icb.2015.87
Knihovny.cz E-zdroje

The adenylate cyclase toxin-hemolysin (CyaA) of Bordetella pertussis is a bi-functional leukotoxin. It penetrates myeloid phagocytes expressing the complement receptor 3 and delivers into their cytosol its N-terminal adenylate cyclase enzyme domain (~400 residues). In parallel, ~1300 residue-long RTX hemolysin moiety of CyaA forms cation-selective pores and permeabilizes target cell membrane for efflux of cytosolic potassium ions. The non-enzymatic CyaA-AC(-) toxoid, has repeatedly been successfully exploited as an antigen delivery tool for stimulation of adaptive T-cell immune responses. We show that the pore-forming activity confers on the CyaA-AC(-) toxoid a capacity to trigger Toll-like receptor and inflammasome signaling-independent maturation of CD11b-expressing dendritic cells (DC). The DC maturation-inducing potency of mutant toxoid variants in vitro reflected their specifically enhanced or reduced pore-forming activity and K(+) efflux. The toxoid-induced in vitro phenotypic maturation of DC involved the activity of mitogen activated protein kinases p38 and JNK and comprised increased expression of maturation markers, interleukin 6, chemokines KC and LIX and granulocyte-colony-stimulating factor secretion, prostaglandin E2 production and enhancement of chemotactic migration of DC. Moreover, i.v. injected toxoids induced maturation of splenic DC in function of their cell-permeabilizing capacity. Similarly, the capacity of DC to stimulate CD8(+) and CD4(+) T-cell responses in vitro and in vivo was dependent on the pore-forming activity of CyaA-AC(-). This reveals a novel self-adjuvanting capacity of the CyaA-AC(-) toxoid that is currently under clinical evaluation as a tool for delivery of immunotherapeutic anti-cancer CD8(+) T-cell vaccines into DC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000975
003      
CZ-PrNML
005      
20200121111257.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/icb.2015.87 $2 doi
024    7_
$a 10.1038/icb.2015.87 $2 doi
035    __
$a (PubMed)26437769
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Svedova, Martina $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
245    10
$a Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells / $c M. Svedova, J. Masin, R. Fiser, O. Cerny, J. Tomala, M. Freudenberg, L. Tuckova, M. Kovar, G. Dadaglio, I. Adkins, P. Sebo,
520    9_
$a The adenylate cyclase toxin-hemolysin (CyaA) of Bordetella pertussis is a bi-functional leukotoxin. It penetrates myeloid phagocytes expressing the complement receptor 3 and delivers into their cytosol its N-terminal adenylate cyclase enzyme domain (~400 residues). In parallel, ~1300 residue-long RTX hemolysin moiety of CyaA forms cation-selective pores and permeabilizes target cell membrane for efflux of cytosolic potassium ions. The non-enzymatic CyaA-AC(-) toxoid, has repeatedly been successfully exploited as an antigen delivery tool for stimulation of adaptive T-cell immune responses. We show that the pore-forming activity confers on the CyaA-AC(-) toxoid a capacity to trigger Toll-like receptor and inflammasome signaling-independent maturation of CD11b-expressing dendritic cells (DC). The DC maturation-inducing potency of mutant toxoid variants in vitro reflected their specifically enhanced or reduced pore-forming activity and K(+) efflux. The toxoid-induced in vitro phenotypic maturation of DC involved the activity of mitogen activated protein kinases p38 and JNK and comprised increased expression of maturation markers, interleukin 6, chemokines KC and LIX and granulocyte-colony-stimulating factor secretion, prostaglandin E2 production and enhancement of chemotactic migration of DC. Moreover, i.v. injected toxoids induced maturation of splenic DC in function of their cell-permeabilizing capacity. Similarly, the capacity of DC to stimulate CD8(+) and CD4(+) T-cell responses in vitro and in vivo was dependent on the pore-forming activity of CyaA-AC(-). This reveals a novel self-adjuvanting capacity of the CyaA-AC(-) toxoid that is currently under clinical evaluation as a tool for delivery of immunotherapeutic anti-cancer CD8(+) T-cell vaccines into DC.
650    _2
$a adenylátcyklasový toxin $x genetika $x imunologie $7 D037361
650    _2
$a adjuvancia imunologická $x genetika $7 D000276
650    _2
$a zvířata $7 D000818
650    _2
$a CD4-pozitivní T-lymfocyty $x imunologie $7 D015496
650    _2
$a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
650    _2
$a protinádorové vakcíny $x imunologie $7 D019496
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a permeabilita buněčné membrány $7 D002463
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a dendritické buňky $x imunologie $x mikrobiologie $7 D003713
650    _2
$a iontový transport $7 D017136
650    12
$a aktivace lymfocytů $7 D008213
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a cytotoxické proteiny tvořící póry $x genetika $x imunologie $7 D052899
650    _2
$a proteinové domény $x genetika $x imunologie $7 D000072417
650    _2
$a mitogenem aktivované proteinkinasy p38 $x metabolismus $7 D048051
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Masin, Jiri $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
700    1_
$a Fiser, Radovan $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Cerny, Ondrej $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
700    1_
$a Tomala, Jakub $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
700    1_
$a Freudenberg, Marina $u Department of Pneumology and BIOSS, Albert Ludwig University, Freiburg, Germany.
700    1_
$a Tuckova, Ludmila $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
700    1_
$a Kovar, Marek $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
700    1_
$a Dadaglio, Gilles $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris, France. INSERM, U1041, Paris, France.
700    1_
$a Adkins, Irena $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic. Sotio a.s., Prague, Czech Republic. $7 gn_A_00001802
700    1_
$a Sebo, Peter $u Institute of Microbiology of the ASCR, v.v.i., Prague; Czech Republic.
773    0_
$w MED00002199 $t Immunology and cell biology $x 1440-1711 $g Roč. 94, č. 4 (2016), s. 322-33
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26437769 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20200121111634 $b ABA008
999    __
$a ok $b bmc $g 1180115 $s 961542
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 94 $c 4 $d 322-33 $e 20151006 $i 1440-1711 $m Immunology and cell biology $n Immunol Cell Biol $x MED00002199
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Možnosti archivace